Evidence map›Paper›PMID 39879323›Full record

ArticleACS infectious diseases2025

Role of the Mobile Active Site Flap in IMP Dehydrogenase Inhibitor Binding.

Xingyou Wang, Masha M Rosenberg, Youngchang Kim, Natalia Maltseva, Gregory D Cuny, Andrzej Joachimiak, Petr Kuzmič, Lizbeth Hedstrom

Abstract read
In one paragraph

Article in ACS infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Xingyou WangDepartment of Chemistry, Brandeis University, Waltham, Massachusetts 02454, United States.
Masha M RosenbergDepartment of Biology, Brandeis University, Waltham, Massachusetts 02454, United States.
Youngchang KimCenter for Structural Biology of Infectious Diseases, Consortium for Advanced Science and Engineering, University of Chicago, Chicago, Illinois 60667, United States.
Natalia MaltsevaCenter for Structural Biology of Infectious Diseases, Consortium for Advanced Science and Engineering, University of Chicago, Chicago, Illinois 60667, United States.
Gregory D CunyDepartment of Pharmacological and Pharmaceutical Sciences, College of Pharmacy, University of Houston, Houston, Texas 77204, United States.ORCID 0000-0002-3188-4748
Andrzej JoachimiakCenter for Structural Biology of Infectious Diseases, Consortium for Advanced Science and Engineering, University of Chicago, Chicago, Illinois 60667, United States.
Petr KuzmičBioKin Ltd., Watertown, Massachusetts 02472, United States.
Lizbeth HedstromDepartment of Chemistry, Brandeis University, Waltham, Massachusetts 02454, United States.ORCID 0000-0001-8432-3322

Funding

TO PROVIDE SCIENTIFIC SUPPORT TO THE CENTERS FOR RESEARCH ON STRUCTURAL BIOLOGY OF INFECTIOUS DISEASES.75N93022C00035 · NIAID · NORTHWESTERN UNIVERSITY AT CHICAGO · PI SATCHELL, KARLA · 2022 to 2025
$20.7M
XRAY CRYSTALLOGRAPHIC STRUCTURE ANALYSIS: PROTEIN SORTINGP41RR001081 · NCRR · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI COHEN, BRUCE E · 1985 to 2011
$17.6M
IMPDH inhibitors for the treatment of Cryptosporidium infectionsR01AI125362 · NIAID · UNIVERSITY OF HOUSTON · PI CUNY, GREGORY D · 2016 to 2020
$3.8M
Opportunities for multi-target drug discovery in tuberculosisR21AI138048 · NIAID · BRANDEIS UNIVERSITY · PI HEDSTROM, LIZBETH K. · 2019 to 2020
$445k
NCRR NIH HHS P41 RR001081NIAID NIH HHS 75N93022C00035NIAID NIH HHS HHSN272201700060CNIAID NIH HHS R01 AI125362NIAID NIH HHS R21 AI138048
6 · The paper itself

Abstract

Inosine 5'-monophosphate dehydrogenase (IMPDH) is a promising antibiotic target. This enzyme catalyzes the NAD-dependent oxidation of inosine 5'-monophosphate (IMP) to xanthosine 5'-monophosphate (XMP), which is the rate-limiting step in guanine nucleotide biosynthesis. Bacterial IMPDH-specific inhibitors have been developed that bind to the NAD

Indexed as

Bacillus anthracisEnzyme InhibitorsIMP DehydrogenaseBacterial ProteinsBinding SitesCatalytic DomainCrystallography, X-RayModels, MolecularProtein BindingBacterial ProteinsEnzyme InhibitorsIMP Dehydrogenaseantibioticsenzyme kineticsIMPDHinhibitor selectivitypresteady-state kineticsSTD-NMR

Identifiers

PMID39879323
PMCPMC11841048

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.